Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05780970 · ClinicalTrials.gov registry record
Exploring the Familial Reach of Adolescent Obesity Treatment
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 55
- Enrollment target
NCT05780970: Completed study, sponsored by Virginia Commonwealth University.
NCT05780970 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05780970 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
An observational study ancillary to the randomized clinical trial (RCT) TEENS+ (R01HD095910), a family-based lifestyle intervention, for adolescents with obesity, to determine: 1) if family-wide changes to the shared home environment are implemented, 2) if ripple effects to untreated family members are observed, and 3) whether these changes are predictive of adolescents' weight management success. Funding support from NIH via R21HD105906.
Primary Outcome
Changes in the home food available and the home exercise and electronic media environment.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2024-06-29 |
What the finished NCT05780970 record still lists
NCT05780970 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT05780970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05780970 about?
NCT05780970 is a clinical study titled "Exploring the Familial Reach of Adolescent Obesity Treatment". An observational study ancillary to the randomized clinical trial (RCT) TEENS+ (R01HD095910), a family-based lifestyle intervention, for adolescents with obesity, to determine: 1) if family-wide changes to the shared home environment are implemented, 2) if ripple effects to untreated family members ...
What is the current status of trial NCT05780970?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2022-01-18. Estimated completion is 2024-06-29.
What interventions are being tested in trial NCT05780970?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05780970?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI